IDELALISIB (IDELALISIB) — FDA Approval ANDA216921 (NATCO)
IDELALISIB (IDELALISIB) — FDA Approval ANDA216921 (NATCO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IDELALISIB; Active ingredients: IDELALISIB; Application number: ANDA216921.
| Brand name | IDELALISIB |
|---|---|
| Active ingredients | IDELALISIB |
| Application number | ANDA216921 |
| Sponsor | NATCO |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20260217 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →